ADH1A and hepatocellular carcinoma: PYCR2 (pyrroline-5-carboxylate reductase 2) and ADH1A (alcohol dehydrogenase 1 A (class I), alpha polypeptide) are recently identified as prognostic biomarkers in HBV-related HCC, involving metabolic reprogramming [20].